Vanguard Group Inc Lexaria Bioscience Corp. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Vanguard Group Inc holds 93,586 shares of LEXX stock, worth $282,629. This represents 0.0% of its overall portfolio holdings.
Number of Shares
93,586
Previous 85,156
9.9%
Holding current value
$282,629
Previous $309,000
15.86%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding LEXX
# of Institutions
29Shares Held
2.06MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.02MShares$3.08 Million0.04% of portfolio
-
Invenomic Capital Management LP Boston, MA514KShares$1.55 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA115KShares$346,6440.0% of portfolio
-
Gen Trust, LLC60KShares$181,2000.01% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL48.8KShares$147,3760.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $18M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...